Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.18 AUD | +12.50% | -2.70% | 0.00% |
Apr. 23 | Microba's Revenue Climbs 297% in Fiscal Q3 | MT |
Apr. 10 | Microba Life Sciences Secures AU$6 Million Tax Rebate for Fiscal Year 2023; Shares Fall 5% | MT |
Business Summary
Sales per Business
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Testing Services
100.0
%
| 5 | 100.0 % | 5 | 100.0 % | +15.60% |
Sales per region
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Australia
58.3
%
| 3 | 55.9 % | 3 | 58.3 % | +20.59% |
Europe
20.0
%
| 1 | 16.5 % | 1 | 20.0 % | +39.69% |
United States
10.2
%
| 1 | 16.3 % | 1 | 10.2 % | -27.56% |
United Arab Emirates
8.4
%
| 0 | 5.7 % | 0 | 8.4 % | +71.27% |
New Zealand
3.0
%
| 0 | 5.5 % | 0 | 3.0 % | -36.96% |
United Kingdom
0.0
%
| 0 | 0.0 % | 0 | 0.0 % | +78.87% |
Singapore
0.0
%
| - | - | 0 | 0.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Luke Reid
CEO | Chief Executive Officer | - | - |
James Heath
DFI | Director of Finance/CFO | - | - |
Yao Liu
CTO | Chief Tech/Sci/R&D Officer | - | - |
Lutz Krause
CTO | Chief Tech/Sci/R&D Officer | - | - |
Trent Munro
PRN | Corporate Officer/Principal | - | 22-04-05 |
Drew Webb
SAM | Sales & Marketing | - | - |
Mark Parker
PRN | Corporate Officer/Principal | - | - |
Peter Webse
SEC | Corporate Secretary | 61 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Capone
BRD | Director/Board Member | 61 | 21-03-17 |
Director/Board Member | - | 22-09-07 | |
Hyung-Tae Kim
BRD | Director/Board Member | 61 | - |
Pasquale Rombola
CHM | Chairman | - | - |
Gene Tyson
FOU | Founder | - | - |
Ian Frazer
BRD | Director/Board Member | - | - |
Richard Bund
BRD | Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 447,851,977 | 258,633,813 ( 57.75 %) | 0 | 57.75 % |
Company contact information
Sector
Sales per Business
Sales per region
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
0.00% | 52.57M | |
-17.89% | 8.25B | |
+39.20% | 3.58B | |
-39.11% | 2.46B | |
-8.06% | 2.46B | |
-7.35% | 2.38B | |
-12.61% | 1.81B | |
-19.01% | 1.55B | |
-40.66% | 1.21B | |
+7.56% | 1.11B |
- Stock Market
- Equities
- MAP Stock
- Company Microba Life Sciences Limited